Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs UNICHEM LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA UNICHEM LAB DISHMAN PHARMA/
UNICHEM LAB
 
P/E (TTM) x 30.0 -72.5 - View Chart
P/BV x 3.3 1.0 335.5% View Chart
Dividend Yield % 0.7 1.1 61.4%  

Financials

 DISHMAN PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
UNICHEM LAB
Mar-22
DISHMAN PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs374375 99.9%   
Low Rs129198 65.3%   
Sales per share (Unadj.) Rs197.0180.3 109.2%  
Earnings per share (Unadj.) Rs21.24.8 437.2%  
Cash flow per share (Unadj.) Rs34.717.8 195.0%  
Dividends per share (Unadj.) Rs2.004.00 50.0%  
Avg Dividend yield %0.81.4 56.9%  
Book value per share (Unadj.) Rs179.9370.4 48.6%  
Shares outstanding (eoy) m80.7070.41 114.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.6 80.5%   
Avg P/E ratio x11.959.1 20.1%  
P/CF ratio (eoy) x7.316.1 45.1%  
Price / Book Value ratio x1.40.8 181.1%  
Dividend payout %9.482.5 11.4%   
Avg Mkt Cap Rs m20,30720,150 100.8%   
No. of employees `000NANA-   
Total wages/salary Rs m5,3553,305 162.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,89812,698 125.2%  
Other income Rs m265475 55.9%   
Total revenues Rs m16,16313,173 122.7%   
Gross profit Rs m4,103728 563.7%  
Depreciation Rs m1,091912 119.6%   
Interest Rs m94461 1,546.9%   
Profit before tax Rs m2,334230 1,013.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624-111 -562.2%   
Profit after tax Rs m1,710341 501.1%  
Gross profit margin %25.85.7 450.2%  
Effective tax rate %26.7-48.2 -55.5%   
Net profit margin %10.82.7 400.3%  
BALANCE SHEET DATA
Current assets Rs m11,01816,484 66.8%   
Current liabilities Rs m9,5175,521 172.4%   
Net working cap to sales %9.486.3 10.9%  
Current ratio x1.23.0 38.8%  
Inventory Days Days57128 44.5%  
Debtors Days Days31,424 0.2%  
Net fixed assets Rs m18,78716,660 112.8%   
Share capital Rs m161141 114.6%   
"Free" reserves Rs m14,35425,937 55.3%   
Net worth Rs m14,51626,077 55.7%   
Long term debt Rs m4,189890 470.7%   
Total assets Rs m29,80533,144 89.9%  
Interest coverage x3.54.8 72.7%   
Debt to equity ratio x0.30 845.5%  
Sales to assets ratio x0.50.4 139.2%   
Return on assets %8.91.2 733.8%  
Return on equity %11.81.3 900.3%  
Return on capital %17.51.1 1,622.1%  
Exports to sales %24.969.2 35.9%   
Imports to sales %3.710.6 35.3%   
Exports (fob) Rs m3,9568,792 45.0%   
Imports (cif) Rs m5941,345 44.2%   
Fx inflow Rs m4,9528,792 56.3%   
Fx outflow Rs m6971,345 51.8%   
Net fx Rs m4,2557,447 57.1%   
CASH FLOW
From Operations Rs m2,786-2,596 -107.3%  
From Investments Rs m-1,5291,001 -152.7%  
From Financial Activity Rs m-9411,912 -49.2%  
Net Cashflow Rs m317317 99.7%  

Share Holding

Indian Promoters % 61.4 50.9 120.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 23.0 10.4 220.5%  
FIIs % 12.0 1.7 700.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 49.1 78.7%  
Shareholders   52,291 29,573 176.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    CIPLA    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs Unichem Lab

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Unichem Lab Share Price Performance

Period Dishman Pharma Unichem Lab S&P BSE HEALTHCARE
1-Day 2.87% -7.79% -0.10%
1-Month -2.45% -14.45% -1.99%
1-Year 96.38% 65.51% -5.62%
3-Year CAGR 50.28% 31.24% 20.96%
5-Year CAGR 41.17% 4.54% 11.47%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Unichem Lab share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Unichem Lab the stake stands at 50.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Unichem Lab.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Unichem Lab paid Rs 4.0, and its dividend payout ratio stood at 82.5%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Unichem Lab.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.